# Teladoc Health account plan

> Teladoc Health is a virtual care company serving employers, health plans and consumers via BetterHelp, with FY2025 revenue of $2,530.0 million.

## At a glance

Teladoc Health (NYSE: TDOC), headquartered in New York, provides virtual care across urgent, primary, chronic and mental health, selling to employers, health plans, hospitals and health systems (Integrated Care) and to consumers through its BetterHelp therapy brand. It completed 17.1 million telehealth visits in 2025, and 83% of revenue comes from access fees charged per member, employee or participant per month. FY2025 revenue was $2,530.0 million, down 2%, with a net loss of $200.3 million and Adjusted EBITDA of $281.1 million. It had approximately 5,600 employees at December 31, 2025 (58% in the U.S.), and is led by CEO Charles Divita.

## Business units

- **Integrated Care** (about 62% of FY2025 revenue ($1,579.6 million)): Virtual primary, urgent, mental health and chronic care for members of employers and health plans, plus connected care hardware and software for hospitals, with international operations headquartered in Barcelona. FY2025 revenue rose 3% with a 15.1% Adjusted EBITDA margin; in Q3 2026 revenue was $398.5 million (+2%), margin 18.8%, with 100.1 million U.S. members and chronic care enrollment up 15% to 1.344 million.
- **BetterHelp** (about 38% of FY2025 revenue ($950.4 million)): Consumer online therapy through nearly 35,000 licensed clinicians, paid weekly or monthly or, increasingly, through insurance. FY2025 revenue fell 9% and Q3 2026 revenue fell 13% to $206.6 million as cash-pay demand declined, while insurance revenue grew to $32.1 million.

## Strategic priorities

- **Teladoc 1 care model**: Launched in July 2026, Teladoc 1 is a comprehensive, AI-assisted care model with a multidisciplinary team and the Pulse intelligence engine; broader availability is planned for 2027, with some revenue impact in 2027 and more in 2028.
- **BetterHelp in-network pivot**: Insurance coverage reached 27 thousand sessions a week (annualized run rate over $140 million) with over 11 thousand credentialed therapists; the goal is at least $200 million annualized run rate exiting 2027.
- **Hybrid care and global presence**: Hybrid care drove growth in Canada, France and Australia; in the U.S. Teladoc acquired a long-time partner providing virtual clinical services to hospitals and added AI features to its Solo platform.
- **Operational excellence**: Offshoring, automation and real estate consolidation, plus a 30% increase in member self-service interactions in U.S. Integrated Care via AI-enabled digital experiences.
- **Outcomes-based Integrated Care**: Upgrades to the Prism care platform, cardiometabolic programs, AI risk stratification and participation in outcomes-based arrangements.

## Latest results

In Q3 2026 (quarter to September 30, 2026) revenue was $605.1 million, down 3%, with a net loss of $26.9 million against $49.5 million a year earlier and Adjusted EBITDA of $79 million (+13.5%, 13.1% margin). Integrated Care grew 2% with an 18.8% margin, while BetterHelp revenue fell 13% as cash-pay revenue dropped 25%, partly offset by insurance revenue of $32.1 million. Cash was $849.9 million. After materially reducing BetterHelp expectations in July 2026, management raised 2026 guidance in October to revenue of $2.39-2.44 billion, Adjusted EBITDA of $277-303 million and free cash flow of $135-165 million.

## Investments and deals

- **2025 acquisitions**: Catapult Health ($65.3 million, February 2025), Uplift Health Technologies ($29.6 million plus $12.7 million accrued, April 2025, the basis of insurance-covered therapy) and Telecare Australia ($16.6 million, August 2025).
- **U.S. hospital virtual services**: In October 2026 Teladoc completed the acquisition of a long-time partner that provides virtual clinical services to U.S. hospitals and health systems.
- **Technology development**: Capitalized software was $118.6 million in FY2025 and $91.5 million in the first nine months of 2026, supporting Prism, Pulse and Teladoc 1.
- **Convertible notes plan**: For the $1 billion convertible notes due June 2027, Teladoc plans to repurchase a substantial portion, potentially before year-end, then repay the rest at maturity.

## Challenges and risks

- **BetterHelp cash-pay decline**: In May 2026 cash-pay decline accelerated beyond plan while insurance demand outran credentialed-provider capacity; about 70% of potential users prefer insurance.
- **Revenue decline and losses**: Revenue fell 2% in FY2025 and 3% in Q3 2026; the accumulated deficit was $16,430.2 million at end-2025.
- **Client concentration and competition**: The top five Clients were 19% of total revenue and 31% of Integrated Care revenue, and health plans building competing services have already caused Client losses.
- **Goodwill impairment risk**: Remaining goodwill of $283.2 million is all in BetterHelp and could be impaired by weaker performance or a sustained share-price decline.
- **Regulation of clinical practice**: Oregon and California tightened corporate-practice-of-medicine laws, with several other states considering similar bills in 2026.

## What leadership says

> "This quarter reflected solid execution across the business and underlying traction on initiatives supporting our strategic priorities." — Charles Divita, Chief Executive Officer, Q3 2026 earnings call, October 28, 2026

> "Teladoc 1 really brings the full breadth of what we can do to the individual" — Charles Divita, Chief Executive Officer, Q3 2026 earnings call, October 28, 2026

> "Approximately 70% of potential users indicating a preference for insurance and as much as 80% in certain markets." — Charles Divita, Chief Executive Officer, Q2 2026 earnings call, July 29, 2026, explaining the BetterHelp reset

> "We remain confident in our strategy." — Charles Divita, Chief Executive Officer, Q2 2026 earnings call, July 29, 2026


## Where a supplier can help

- **Provider credentialing and capacity**: BetterHelp's insurance demand outran credentialed-provider capacity, so credentialing, payer enrollment, scheduling and matching tools address its main constraint.
- **Revenue cycle for insurance therapy**: The shift to insurance-covered sessions recognized per visit creates needs for claims, eligibility and revenue cycle management services.
- **AI clinical and member tools**: Teladoc 1, the Pulse engine, ambient documentation and AI self-service open room for AI, data integration and clinical workflow partners.
- **Outcomes measurement for buyers**: Clients want demonstrated ROI and outcomes, so analytics and outcomes-measurement suppliers can support outcomes-based arrangements and renewals.
- **Cost efficiency programs**: Ongoing restructuring, offshoring and automation (about $20.0 million of 2026 restructuring costs) point to automation, BPO and procurement services.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Teladoc Health Annual Report on Form 10-K for fiscal year 2025](https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm)

Annual report · 2026-02-26

- Teladoc Health describes itself as "the global leader in virtual care": 17.1 million telehealth visits in 2025, two reportable segments (Integrated Care and BetterHelp), approximately 5,600 employees at December 31, 2025 (58% in the U.S., 42% international).
- FY2025 revenue was $2,530.0 million, down 2% from $2,569.6 million; net loss narrowed to $200.3 million (from $1,001.2 million, which included $790.0 million of goodwill impairment); Adjusted EBITDA $281.1 million vs $310.7 million; free cash flow $166.9 million.
- Integrated Care (B2B to health plans, employers, hospitals and health systems): revenue $1,579.6 million (+3%), Adjusted EBITDA margin 15.1%; 101.8 million U.S. Integrated Care members (+9%), 1.19 million chronic care enrollees, $1.29 average monthly revenue per member (from $1.37).
- BetterHelp (consumer virtual therapy, nearly 35,000 licensed clinicians): revenue $950.4 million (-9%), paying users down 5% to 0.39 million, Adjusted EBITDA margin 4.4% (from 7.5%); insurance coverage being rolled out nationwide to lift conversion.
- 83% of revenue comes from access fees (PMPM/PEPM/PPPM); top five Clients were 19% of total revenue and 31% of Integrated Care revenue; U.S. revenue $2,071.7 million (-4%), International $458.2 million (+12%).
- Strategy: richer Integrated Care offering (Prism care platform, Teladoc Health Pulse AI intelligence engine, cardiometabolic programs, outcomes-based deals), scaled mental health, deeper international presence (international HQ in Barcelona), and operational excellence (offshoring, automation, real estate consolidation).
- 2025 M&A: Catapult Health ($65.3 million, Feb 2025), Uplift Health Technologies (insurance-covered therapy, $29.6 million plus $12.7 million accrued, Apr 2025), Telecare Australia ($16.6 million, Aug 2025); acquired goodwill fully impaired ($71.8 million).
- Balance sheet: $781.1 million cash; Livongo Notes and 2025 Notes repaid ($551.7 million financing outflow); $1.0 billion 1.25% convertible notes due 2027 remain; new five-year $300.0 million revolver (July 2025), undrawn.
- Key risks: history of losses (accumulated deficit $16,430.2 million), client concentration and health plans building competing services, further goodwill impairment (market cap fell below book value after year-end), corporate-practice-of-medicine laws tightening, tariffs on device components.
- Restructuring continues: $15.0-$20.0 million pre-tax costs expected in 2026; all chronic condition management clients to move to the Teladoc Health brand by December 31, 2026.

### [Teladoc Health Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/1477449/000147744926000052/tdoc-20260930.htm)

Interim report · 2026-10-29

- Q3 2026 (quarter to September 30, 2026) revenue $605.1 million, down 3%; nine-month revenue $1,825.9 million, down 3%; Q3 net loss $26.9 million ($0.15 per share) vs $49.5 million.
- Integrated Care Q3 revenue $398.5 million (+2%), Adjusted EBITDA $74.9 million, margin 18.8% (17.0% a year earlier); nine-month margin 16.5%.
- BetterHelp Q3 revenue $206.6 million (-13%): Consumer and Other (cash pay) $174.5 million (-25%) vs Insurance Covered Services $32.1 million (from $3.7 million); Adjusted EBITDA margin 2.2%.
- In May 2026 cash-pay decline accelerated beyond plan while insurance demand outran credentialed-provider capacity; in July 2026 the company "materially reduced" BetterHelp 2026 revenue expectations.
- Response: BetterHelp advertising cut ($98.8 million in Q3, -27%), resources moved to U.S. provider capacity and insurance platform, reduced near-term investment in cash-pay markets outside the U.S.
- U.S. Integrated Care members fell 2% to 100.1 million (government-program enrollment cuts at health plan clients); chronic care enrollment rose 15% to 1.344 million on multi-condition bundles; average monthly revenue per member $1.33.
- Cash $849.9 million; nine-month operating cash flow $180.6 million; undrawn $300.0 million revolver; management expects to refinance or repay the 2027 Notes at maturity.
- Restructuring costs $17.3 million in nine months; about $20.0 million expected for 2026; new risk factor on BetterHelp cash-pay decline and possible BetterHelp goodwill impairment ($283.2 million).

### [Teladoc Health Q3 2026 earnings call transcript](https://www.fool.com/earnings/call-transcripts/2026/10/29/teladoc-tdoc-q3-2026-earnings-call-transcript/)

Executive talk · Charles Divita, Chief Executive Officer · 2026-10-29

- CEO Charles (Chuck) Divita: Q3 2026 revenue near the top of guidance and Adjusted EBITDA above it; new CFO Mike Grasher joined in late August 2026.
- Consolidated revenue $605 million (-3.4%), Adjusted EBITDA $79 million (+13.5%), margin 13.1%; cash $850 million; net debt to trailing Adjusted EBITDA 0.5x.
- 2026 guidance raised: revenue $2.39-2.44 billion, Adjusted EBITDA $277-303 million, free cash flow $135-165 million, stock-based compensation below $50 million.
- Teladoc 1 (comprehensive, AI-assisted care model launched July 2026): initial launch partners live, broader availability in 2027, some revenue impact in 2027 and more in 2028.
- Hybrid care push in U.S. hospitals: acquisition of a long-time partner providing virtual clinical services to U.S. hospitals; new AI features in the Solo platform (contact-free vitals, ambient documentation).
- BetterHelp insurance: $32 million revenue in Q3, 27 thousand sessions a week (annualized run rate over $140 million), over 11 thousand credentialed therapists, 36% of acquired U.S. users from insurance; goal of at least $200 million annualized run rate exiting 2027.
- BetterHelp cash pay keeps shrinking: ad spend down 27% in Q3, a further cut in Q4, and a mid-to-high-20% decline in 2027.
- Integrated Care margin 18.8% (+180 bps); international grew double digits; bookings "generally in line" with expectations.
- $1 billion convertible notes due June 2027: plan to repurchase a substantial portion, potentially before year-end, then repay the rest at maturity.

### [Teladoc Health Q2 2026 earnings call transcript](https://www.fool.com/earnings/call-transcripts/2026/08/07/teladoc-health-tdoc-q2-2026-earnings-call-transcript/)

Executive talk · Charles Divita, Chief Executive Officer · 2026-07-29

- Q2 2026 call (July 29, 2026), CEO Charles Divita alone: BetterHelp outlook cut after cash-pay users fell faster than expected from mid-May.
- Consolidated revenue $607 million, Adjusted EBITDA $66 million (10.8% margin), net loss $0.21 per share, free cash flow $36 million, cash $774 million.
- 2026 guidance reset: revenue $2.36-2.45 billion (5% lower at the midpoint), Adjusted EBITDA $271-303 million, BetterHelp revenue $770-830 million, insurance revenue $90-105 million reaffirmed.
- About 70% of potential BetterHelp users prefer insurance (up to 80% in some markets); insurance demand outran credentialed-therapist capacity.
- Actions: insurance accelerated to all remaining states (20 states, nearly 1/3 of U.S. population) for a national footprint; ad spend cut; non-U.S. BetterHelp deprioritized near term.
- Insurance metrics: over 150 million in-network lives, more than 8 thousand credentialed professionals, over 20 thousand sessions a week (run rate over $110 million).
- Teladoc 1 launched: comprehensive care model with a multidisciplinary team and Pulse AI, broadly available January 2027, starting with cardiometabolic populations.
- Integrated Care: revenue $394 million (+0.7%), margin 16.5%; hybrid care revenue +30%; chronic care enrollment 1.27 million (+14%); one client implementation deferred to 2027.

## Questions about Teladoc Health

### What does Teladoc Health do?

Teladoc Health provides virtual medical and mental health care to members of employers and health plans, technology and virtual services to hospitals, and consumer online therapy through BetterHelp.

### What is Teladoc Health's revenue?

FY2025 revenue was $2,530.0 million, down 2%. For 2026 Teladoc guides revenue of $2.39-2.44 billion.

### How many employees does Teladoc Health have?

Teladoc had approximately 5,600 employees at December 31, 2025, 58% in the U.S. and 42% internationally.

### What is Teladoc Health's strategy?

Its four priorities are enhancing Integrated Care (including Teladoc 1), leveraging its scaled mental health position through BetterHelp's insurance pivot, building on its global and hybrid care presence, and operational excellence.

### Who leads Teladoc Health?

Charles Divita is Chief Executive Officer, Mike Grasher joined as CFO in late August 2026, and Kenneth H. Paulus is Chairman of the Board.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
